Skip to main content

Table 3 Postoperative Characteristics

From: Dexmedetomidine for prevention of postoperative pulmonary complications in patients after oral and maxillofacial surgery with fibular free flap reconstruction:a prospective, double-blind, randomized, placebo-controlled trial

Characteristic Dexmedetomidine group Placebo group P value
(n = 80) (n = 80)
Length of stay in PACU, median (IQR), min 855 (675, 970) 923 (730, 1020) 0.073
Medication in PACU, median (IQR), min
 Dexmedetomidine in PACU 168 (160, 184) 0 (0, 0) 0.000
 Total Dexmedetomidine on operation day a 360 (338, 378) 0 (0, 0) 0.000
 Sufentanil in PACU 0 (0, 0) 0 (0, 0) 0.100
 Total sufentanil on operation day a 30 (25, 40) 34 (25, 46) 0.070
Time with tracheotomy tube, median (IQR), d 5(5,6) 5(5,6) 0.551
Total infusion, mean (SD), ml
 The operation day a 1848.65 ± 622.996 1888.44 ± 690.296 0.702
 The first day after surgery 931.69 ± 1108.510 989.25 ± 1098.572 0.742
 The second day after surgery 861.04 ± 954.420 868.41 ± 1162.951 0.717
NRS for oral and maxillofacial area pain, mean (SD)
 The first day after surgery 1.30 ± 1.226 3.20 ± 1.363 0.000
 The second day after surgery 1.49 ± 1.534 1.53 ± 1.492 0.876
 The Third day after surgery 1.39 ± 1.497 1.44 ± 1.231 0.818
NRS for fibular area pain, mean (SD)
 The first day after surgery 1.59 ± 1.357 3.71 ± 1.070 0.000
 The second day after surgery 1.49 ± 1.369 1.58 ± 1.367 0.686
 The third day after surgery 1.55 ± 1.457 1.43 ± 1.261 0.563
Sleep time, median (IQR), h
 The first day after surgery 6.0 (5.0, 7.0) 4.0 (3.3, 5.0) 0.000
 The second day after surgery 5.0 (4.3, 6.0) 5.0 (4.0, 6.0) 0.520
  1. Abbreviations: PACU Post anesthesia care unit, NRS Numeric rating scale
  2. a Defined the time from the beginning of the surgery to the next morning 0800 h in PACU